UniQure lists 45,000 shares for proposed sale

Uniqure N.V. submitted a Form 144 notice reporting proposed sales of Ordinary Shares to be effected through Citigroup Global Markets, Inc. on 05/08/2026.

Rhea-AI Filing Summary

Uniqure N.V. submitted a Form 144 notice reporting proposed sales of Ordinary Shares to be effected through Citigroup Global Markets, Inc. on 05/08/2026. The filing lists 45,000 (figure present) and details 20,000 vested shares and 25,000 shares from option exercises.

Key Figures

Listed amount: 45,000 Vested shares: 20,000 shares Option exercise shares: 25,000 shares +3 more

6 metrics

Listed amount 45,000 figure present alongside broker and date 05/08/2026

Vested shares 20,000 shares Vested Shares to be sold on 05/08/2026

Option exercise shares 25,000 shares Stock options exercise listed for 05/08/2026, cash

Broker-dealer Citigroup Global Markets, Inc. Named intermediary at 390 Greenwich St, New York

Prior sale example 1 1,660 shares Sale on 03/02/2026 listed in past 3 months

Prior sale example 2 808 shares Sale on 03/04/2026 listed in past 3 months

Key Terms

Form 144, Vested Shares, Stock options exercise, Broker-dealer

4 terms

Form 144 regulatory

"submitted a Form 144 notice reporting proposed sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Vested Shares financial

"Vested Shares | Uniqure N.V. | 20000 | 05/08/2026"

Stock options exercise financial

"Stock options exercise | Uniqure N.V. | 25000 | 05/08/2026"

Broker-dealer regulatory

"Citigroup Global Markets, Inc 390 Greenwich St New York NY"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UniQure (QURE) Form 144 disclose about shares to be sold?

The Form 144 discloses proposed sales through Citigroup Global Markets, Inc. on 05/08/2026, listing 45,000 and noting 20,000 vested shares and 25,000 from option exercises as the sources of shares.

How many vested shares does the QURE filing list for proposed sale?

The filing explicitly lists 20,000 vested shares designated for sale on 05/08/2026. These are presented separately from shares described as issuable upon option exercise in the same Form 144 notice.

Does the Form 144 show recent sales by the reporting person for QURE?

Yes. The excerpt lists past sales in the prior three months: 1,660 shares on 03/02/2026 and 808 shares on 03/04/2026, with associated numeric values shown alongside each sale entry.

Which broker-dealer is named for executing the proposed QURE sales?

The notice names Citigroup Global Markets, Inc. at 390 Greenwich St, New York, NY as the broker-dealer through which the proposed transactions are to be effected on the stated date of 05/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 04:00 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001985973
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	uniQure N.V.
SEC File Number	001-36294
Address of Issuer	PAASHEUVELWEG 25A AMSTERDAM NETHERLANDS 1105 BP
Phone	1-339-970-7000
Name of Person for Whose Account the Securities are To Be Sold	Abi-Saab Walid
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Medical Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich St New York NY 10013	45000	1127435.00	63067485	05/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	05/08/2026	Vested Shares	Uniqure N.V.			20000	05/08/2026	Compensation
Ordinary Shares	05/08/2026	Stock options exercise	Uniqure N.V.			25000	05/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Walid Abi-Saab PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP	Ordinary Shares	03/02/2026	1660	16517.00
Walid Abi-Saab PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP	Ordinary Shares	03/04/2026	808	7320.48

144: Remarks and Signature

Remarks	Shares were sold pursuant to 10b5-1 plan adopted September of 2025. Section 3D based indicative market pricing $25 and $25.09742
Date of Notice	05/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)